Imaging Industry Expands Emerging Market Focus
This article was originally published in PharmAsia News
Executive Summary
A recent award from the U.S. Commerce Department comes at an opportune time for the imaging and radiation therapy industry to accelerate its push for regulatory reforms in China and India, says the sector's top lobbyist
You may also be interested in...
AdvaMed Delegates Go To China; Business Ethics Code In The Works
AdvaMed and Chinese device makers agreed to harmonize China's standards for ethical business practices with AdvaMed's code of ethics and other international policies in a memorandum of understanding signed earlier this month
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).